Catalyst
Slingshot members are tracking this event:
Phase 2b data of BCX4161(avoralstat) - OPuS-2 trial - for Hereditarry angioedema due early 1Q 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| BCRX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 08, 2016
Occurred Source:
http://investor.shareholder.com/biocryst/releasedetail.cfm?ReleaseID=953694
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Opus-2, Bcx4161, Oral Prophylaxis-2, Avoralstat
